The latest probe points to challenges for India’s biggest drugmaker after whistle-blower complaints on corporate governance lapses triggered a stock slide last year.
In 2015, billionaire Dilip Shanghvi bought 23% stake for Rs 18 billion, but Suzlon still hasn’t exited India’s debt-restructuring program, missing deadlines since 2017.
Britain’s failure to secure the oil of Arabia in the 1950s was no misjudgement. The sun was setting on the Empire, and a new hegemon had emerged. Is another anarchy on the rise now?
The rupee’s fall to record lows amid rising energy-import costs and capital outflows is raising expectations that RBI Governor Sanjay Malhotra may be forced to abandon his pause and hike rates.
American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.
COMMENTS